U.S. Beverage Stock News

NYSE:FRO
NYSE:FROOil and Gas

Frontline (FRO) Is Up 9.3% After Q4 Earnings Beat And Accelerated VLCC Fleet Renewal – What's Changed

In late February 2026, Frontline plc reported fourth-quarter 2025 results showing revenue of US$624.51 million and net income of US$227.93 million, with earnings of US$1.02 per share from continuing operations. Alongside the earnings beat, Frontline accelerated a major fleet renewal by selling eight older VLCCs and acquiring nine scrubber-fitted eco-VLCC newbuildings, signaling a shift toward a younger, more fuel-efficient tanker portfolio. Next, we’ll examine how this fleet renewal,...
NasdaqGS:NMRK
NasdaqGS:NMRKReal Estate

Is It Time To Reassess Newmark Group (NMRK) After Recent Share Price Weakness?

If you are wondering whether Newmark Group's share price reflects its underlying worth today, you are not alone. This article is set up to help you frame that question clearly. The stock recently closed at US$14.52, with returns of a 3.8% decline over 7 days, 18.6% decline over 30 days, 14.4% decline year to date and 0.2% decline over the past year, while the 3 year and 5 year returns sit at 89.2% and 50.1% respectively. These moves have put valuation back in focus for Newmark Group...
NasdaqGM:CRSP
NasdaqGM:CRSPBiotechs

Vertex Interest Renews CRISPR Therapeutics Takeover Talk And Investor Questions

Renewed acquisition speculation around CRISPR Therapeutics (NasdaqGM:CRSP) has surfaced, with reports that Vertex Pharmaceuticals is exploring a potential purchase. Recent commentary suggests Vertex has engaged legal advisers to assess a possible deal, keeping M&A chatter active around CRISPR Therapeutics. The latest rumors have drawn fresh attention from investors watching for potential corporate activity in the gene editing space. CRISPR Therapeutics focuses on gene editing therapies, an...
NasdaqGS:APP
NasdaqGS:APPSoftware

How Investors Are Reacting To AppLovin (APP) Record Q4, AI Pivot and Rising Regulatory Scrutiny

In February 2026, AppLovin reported its strongest quarter to date, with Q4 2025 revenue of US$1.7 billion and EPS of US$3.24, both above prior Wall Street forecasts, while guiding Q1 2026 revenue to US$1.75 billion–US$1.78 billion and continuing its pivot toward an AI-driven, high-margin adtech platform. At the same time, the company’s transformation away from gaming and toward its AXON AI engine and e‑commerce advertising is being weighed against regulatory scrutiny, including an active SEC...
NYSE:SNOW
NYSE:SNOWIT

Snowflake Lawsuits And CEO Exit Raise Questions On Valuation And Risks

Multiple securities class action lawsuits have been filed against Snowflake after recent disclosures on product efficiency gains, pricing changes, and revenue impact. Shareholders are also challenging the handling and disclosure of the unexpected retirement of CEO Frank Slootman. The cases focus on whether Snowflake provided sufficient information about how these shifts could affect its financial results and risk profile. For investors watching NYSE:SNOW, this legal pushback comes at a time...
NYSE:CRI
NYSE:CRILuxury

Carter's Revenue Recovery Tests Productivity Reset And Margin Resilience

Carter's (NYSE:CRI) reports its first year-over-year annual revenue growth since 2021, supported by retail and wholesale performance. The company sees increased traction with Gen Z and Millennial families, highlighting renewed brand interest. Margins remain under pressure from tariffs and higher product costs, with guidance for lower profitability in the first half of 2026. Carter's plans a productivity overhaul, including roughly 150 store closures, workforce changes, and higher...
NasdaqGS:SSNC
NasdaqGS:SSNCProfessional Services

Assessing SS&C Technologies (SSNC) After Recent Share Price Weakness And DCF Upside Potential

If you are wondering whether SS&C Technologies Holdings is offering fair value at its current price, or if the market is mispricing it, this article walks through the key numbers that matter for you as a shareholder or potential investor. The stock last closed at US$75.29, with a recent 5.5% gain over 7 days sitting against a 12.2% decline year to date and a 14.4% decline over the past year. The 3 year and 5 year returns are 31.4% and 21.6% respectively. These mixed returns sit alongside an...
NasdaqGS:LAUR
NasdaqGS:LAURConsumer Services

How Laureate Education’s Bigger Buyback and 2026 Outlook At Laureate Education (LAUR) Has Changed Its Investment Story

On 19 February 2026, Laureate Education reported fourth-quarter 2025 results showing higher sales and earnings per share than a year earlier, issued first-quarter and full-year 2026 revenue guidance, and disclosed completion of a US$218.89 million buyback under its existing program. On the same day, the company also expanded its capital return plans by increasing its share repurchase authorization to US$400 million, signaling management’s confidence in its financial capacity while it...
NYSE:COLD
NYSE:COLDIndustrial REITs

Americold Houston Expansion And Tech Push Tested By Cash Flow Risks

Americold Realty Trust (NYSE:COLD) is expanding its footprint with a new acquisition in Houston in the temperature controlled logistics space. The company is also prioritizing advanced technology across its network, aiming to improve the way it manages temperature controlled storage and distribution. These business moves come as Americold continues to work through risks tied to customer concentration and a reliance on shorter term contracts. Americold’s recent actions come against a mixed...
NasdaqGS:GLXY
NasdaqGS:GLXYCapital Markets

Galaxy Digital Expands Into AI While Valuation Lags Analyst Target

Galaxy Digital (NasdaqGS:GLXY) is expanding into AI and high performance computing data center infrastructure at its Helios campus. The company also plans to launch GalaxyOne in October 2025, a fintech platform that connects traditional and digital asset markets. These moves signal a broader business focus beyond Galaxy Digital's existing digital asset activities. For you as an investor looking at crypto and digital asset firms, Galaxy Digital sits at the intersection of trading, asset...
NasdaqGS:AEP
NasdaqGS:AEPElectric Utilities

American Electric Power Taps AI Data Center Boom With Higher Capex

American Electric Power Company (NasdaqGS:AEP) has expanded its capital expenditure plans by up to $8b through 2030. The additional spending is aimed at meeting rising electricity demand tied to the rapid build out of AI data centers. This move positions AEP as a key utility partner for large scale computing and data infrastructure projects. For investors watching utilities, American Electric Power Company sits at the intersection of power infrastructure and AI driven demand. The stock,...
NasdaqGS:SPSC
NasdaqGS:SPSCSoftware

How Investors Are Reacting To SPS Commerce (SPSC) Earnings Beat, Revenue Miss, and CEO Stock Sale

SPS Commerce recently reported quarterly results that beat earnings-per-share expectations but slightly trailed revenue forecasts, while its CEO Chadwick Collins sold about US$785,000 of stock under a pre-arranged plan and management presented at the Morgan Stanley Technology, Media & Telecom Conference. The mixed earnings outcome, analyst downgrade citing softer 2026 expectations, and insider sale together raise fresh questions about the strength and timing of SPS Commerce’s growth...
NYSE:UTZ
NYSE:UTZFood

Utz Brands Taps Protein And Premium Chips To Support Margin Story

Utz Brands (NYSE:UTZ) introduced new protein-enriched snacks under the Utz brand at the 2026 Natural Products Expo West. The company also rolled out Boulder Canyon Agave Sriracha kettle chips, positioned around gluten-free and non-GMO attributes. These launches target consumer interest in high-protein, better-for-you salty snacks with globally inspired flavors. Utz Brands, known for its salty snacks portfolio across brands such as Utz and Boulder Canyon, is leaning into demand for higher...
NasdaqGM:RYTM
NasdaqGM:RYTMBiotechs

Rhythm Pharmaceuticals Nears Key FDA Calls With Global Growth Potential

Rhythm Pharmaceuticals is moving toward a key FDA decision for IMCIVREE in acquired hypothalamic obesity, with preparations underway for a potential U.S. approval and commercial launch. The company has received constructive FDA feedback at its end of Phase 2 meeting for oral candidate bivamelagon, supporting plans to progress into Phase 3. Rhythm is also working on broader commercial access, reimbursement, and geographic expansion in Europe and Japan for its rare neuroendocrine disease...
NYSE:CRBG
NYSE:CRBGDiversified Financial

Reassessing Corebridge Financial (CRBG) Valuation After Recent Share Price Weakness

Why Corebridge Financial Is Back On Investors’ Radar Corebridge Financial (CRBG) has drawn fresh attention after a period of weak share performance, including negative moves over the past week, month and past 3 months, prompting investors to reassess its fundamentals and valuation. See our latest analysis for Corebridge Financial. The recent 1 day share price return of negative 7.35%, extending to a 30 day share price return of negative 16.19%, suggests momentum has faded in the short term...
NasdaqGS:HNST
NasdaqGS:HNSTPersonal Products

Honest Company (HNST) Valuation Check After Wider Loss Lower Revenue And New US$25m Buyback

Honest Company (HNST) has drawn fresh attention after reporting full year 2025 results that show lower sales and a wider net loss, along with new 2026 guidance and a US$25 million share repurchase program. See our latest analysis for Honest Company. At a share price of US$2.80, recent moves have been mixed, with a strong 7 day share price return of 23.35% and a 30 day share price return of 13.36%. However, a 1 year total shareholder return decline of 48.15% suggests longer term holders have...
NasdaqGM:GCT
NasdaqGM:GCTRetail Distributors

A Look At GigaCloud Technology (GCT) Valuation After Record Results And New Buyback Program

GigaCloud Technology (GCT) drew fresh attention after reporting record Q4 and full year 2025 results, pairing higher revenue and earnings with new Q1 revenue guidance and a sizable share repurchase program. See our latest analysis for GigaCloud Technology. GigaCloud Technology's share price has been volatile around these results, with a 26.58% 7 day share price return and 16.38% 90 day share price return. The 1 year total shareholder return is 161.90%, which hints at strong positive momentum...
NYSE:APAM
NYSE:APAMCapital Markets

Assessing Artisan Partners (APAM) Valuation After Recent Share Price Pullback And Modest Undervaluation Signals

Recent price moves and financial snapshot Artisan Partners Asset Management (APAM) has seen its share price decline about 2.5% over the past day and roughly 9.5% over the past month, putting recent trading action on many investors’ radar. At a last close of US$40.28, the US based investment manager reports annual revenue of about US$1.2b and net income of roughly US$265.9m. See our latest analysis for Artisan Partners Asset Management. While the 1 month share price return of Artisan Partners...
NYSE:LVS
NYSE:LVSHospitality

Marina Bay Sands’ Record EBITDA and STEM Push Could Be A Game Changer For Las Vegas Sands (LVS)

Las Vegas Sands recently reported strong fourth-quarter 2025 results, with adjusted earnings and net revenues rising year over year and beating estimates, driven by record EBITDA at Singapore’s Marina Bay Sands and ongoing investments despite competitive pressure in Macao. Separately, the company’s Sands Cares-funded US$75,000 UNLV STEM for Girls Camp underscores its emphasis on long-term workforce development and inclusion, complementing its resort investments with broader community and...
NasdaqGS:SNDX
NasdaqGS:SNDXBiotechs

Syndax’s Third FDA Win Accelerates Shift To Multi Product Revenues

Syndax Pharmaceuticals secured its third FDA approval within a year, following the launches of Revuforj and Niktimvo. The company is rapidly shifting into a commercial-stage model with revenues now coming from multiple newly approved therapies. Pivotal clinical trials are in progress that could support label expansions and additional indications. Syndax Pharmaceuticals, NasdaqGS:SNDX, is moving from a pure R&D story to an active commercial player, supported by three FDA approved therapies...
NYSE:FIGS
NYSE:FIGSLuxury

Is It Too Late To Consider FIGS (FIGS) After A 238% One-Year Surge?

If you are wondering whether FIGS at around US$15.45 is priced for perfection or still leaves room on the table, you are in the right place. The stock has been very active, with returns of 37.5% over the last week, 42.9% over the last month, 35.6% year to date, and 238.1% over the past year, plus 130.6% over three years. Recent coverage around FIGS has focused on how the company is positioned within the broader consumer durables and apparel space, and how investor interest in this niche has...
NYSE:PACS
NYSE:PACSHealthcare

Is PACS Group’s (PACS) Aggressive Acquisition Plan Strengthening Its Core Skilled Nursing Advantage?

PACS Group, Inc. recently reported its full-year 2025 results, with revenue of US$5.29 billion and net income of US$191.54 million, and issued 2026 guidance calling for revenue between US$5.65 billion and US$5.75 billion alongside a new shelf registration of 8,199,361 common shares for an ESOP-related offering. Management also highlighted continued expansion through acquisitions, high clinical quality ratings across its skilled nursing portfolio, and plans to add roughly five underperforming...
NasdaqGS:FLYW
NasdaqGS:FLYWDiversified Financial

Flywire Taps Payments Veteran As CTO To Drive AI First Growth

Flywire appointed Patrick Blanc as Chief Technology Officer as part of a leadership realignment focused on AI driven product development. Blanc brings payments technology experience from senior roles at Ingenico, Visa, and PayPal. David King moved into the role of Chief Product Officer and Co President of Global Education to support Flywire's product and sector focus. For investors tracking NasdaqGS:FLYW, this leadership reshuffle comes with the stock recently closing at $12.31 and showing...
NYSE:BLDR
NYSE:BLDRBuilding

Builders FirstSource (BLDR) Is Down 5.7% After Weaker 2025 Results And Softer 2026 Outlook - Has The Bull Case Changed?

In February 2026, Builders FirstSource reported past fourth-quarter 2025 sales of US$3,357.9 million and net income of US$31.5 million, alongside full-year 2025 sales of US$15.19 billion and net income of US$435.2 million, while issuing 2026 net sales guidance of US$14.8 billion to US$15.8 billion and confirming no share repurchases under its May 2025 buyback authorization. The sharp year-on-year drop in earnings per share, combined with management’s 2026 revenue outlook and commentary about...